GLOBAL Leaders in
INNOVATION Investing
Top Tier Capital Partners is an investment manager with families of funds focused on primary commitments to venture funds, LP and direct secondaries, and direct investments. For over two decades Top Tier and its predecessor firm have made 160+ global investments backing top investors and innovators.
Why top Tier?Venture investors for the long-haul.
At Top Tier, consistency and integrity drive everything we do. Our value-add lies in our experience, deep networks, industry insights, and superior client service. We work collaboratively with our limited partners to help them build their venture capital programs, partner closely with our managers to offer thoughtful, hands-on counsel, and help our entrepreneurs build the next great technology company. Our relationships are long-lasting, built on trust, and begin, do not end, with the investment.
-
Primaries
Investing in funds managed by venture capital firms around the world across the innovation ecosystem. -
Secondaries
Flexible liquidity solutions for venture capital holdings across limited partnerships and shareholders of venture-backed companies. -
Directs
Investing in innovative and high growth venture-backed companies by partnering with our venture capital relationships, utilizing our data insights and leveraging our entrepreneur network.
Informed insight to maximize potential returns
Our Global Approach.
With offices in the U.S. and London, Top Tier is uniquely positioned to provide insights on global venture capital investments.
Resources + Insights
View All-
Blog
Private IPOs are Here to Stay (For Now)
Blog
Private IPOs are Here to Stay (For Now)
The topic of Private IPOs is getting a lot of interest and is something we have examined before. We previously wrote about the rise of unicorn (private $1B+) valuations and the impact of mega rounds on exit dynamics within private markets. We have spent the last 18 months thinking about what a new normal might look like as companies choose to remain private for longer. A Private IPO is defined as a financing round of $100M or more. While we do not have a crystal ball, we think that the Private IPO is here to stay (for now).
Continue Reading » -
Blog
An Eye Popping $10B exit! In healthcare, nonetheless…
BlogAn Eye Popping $10B exit! In healthcare, nonetheless…
We were just in the middle of (yet another) healthcare study internally when the news of AbbVie’s $10.2B offer for Stemcentrx came out. This post was already in the works and was going to talk about why we still put about 20% of our investment dollars into the healthcare space (the rest goes to technology…
Continue Reading » -
Tweet
Excited to announce today that we have closed $1.2 billion in new commitments for our ninth family of funds!
TweetExcited to announce today that we have closed $1.2 billion in new commitments for our ninth family of funds!
Excited to announce today that we have closed $1.2 billion in new commitments for our ninth family of funds!
Continue Reading »